Italia markets close in 4 hours 24 minutes

ILMN Jun 2024 105.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,67000,0000 (0,00%)
In data: 11:35AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente4,6700
Aperto4,6000
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio105,00
Scadenza2024-06-21
Min-Max giorno4,6000 - 5,0000
Contratto - Min-MaxN/D
Volume144
Open Interest210
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera